Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Both Wegovy and Ozempic are semaglutide – a drug that first entered the US market in 2017 as a diabetes medication. It was ...

To date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...

While Ozempic is not approved for weight loss, some health care providers prescribe the medication off-label for this purpose. Meanwhile, Wegovy and Ozempic come in different dosages: ...

The weight loss and diabetes drug, which is only available on prescription, should be on pharmacy shelves within days ending ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

While the makers of Ozempic have stated that its GLP-1 medication was not made to be used as a weight loss drug, nor should ...

A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.

Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...